Pfizer and Flagship Pioneering are ... potential lupus asset for Flagship’s Pioneering Medicines Valo Health now marks the sixth collaboration for the $7 billion biobucks, 10-program ...

Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...

Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...

Collaboration leverages Logica, a platform offering from Valo Health and Charles River that ... partnership between Flagship Pioneering and Pfizer to accelerate discovery of innovative compounds ...

the result of a strategic collaboration between Charles River and Valo Health, is the industry’s first computation-powered, unified target-to-candidate offering. The platform leverages the ...

"The success of Valo depends on collaborative, talented, and passionate people who connect the seams of science, technology, medicine, and human health. We are excited to welcome Peggy to Valo ...

Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely warranted. Pharmaceutical titan Pfizer (NYSE: PFE) is a case in point.

Pfizer offers a substantial 6.7% dividend yield and has increased its dividend for 16 consecutive years. The stock trades at a forward P/E of just 8.7, close to historical lows. Despite policy ...